PD-1 ANTIBODY

Clinical trials for PD-1 ANTIBODY explained in plain language.

Never miss a new study

Get alerted when new PD-1 ANTIBODY trials appear

Sign up with your email to follow new studies for PD-1 ANTIBODY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New hope for advanced bile duct cancer: triple therapy shows promise

Disease control Completed

This study tested a three-drug combination for people with advanced bile duct cancer that worsened after standard chemotherapy. The treatment included a targeted chemo-delivery into the liver, a pill (apatinib), and an immunotherapy (PD-1 antibody). Twenty adults aged 18-80 with …

Matched conditions: PD-1 ANTIBODY

Phase: PHASE2 • Sponsor: Sichuan Cancer Hospital and Research Institute • Aim: Disease control

Last updated Jun 01, 2026 17:56 UTC

PD-1 ANTIBODY

Get alerted when new PD-1 ANTIBODY trials appear

New hope for advanced bile duct cancer: triple therapy shows promise